AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / LABORATORY ANALYTICAL INSTRUMENTS
Illumina Inc
XNAS · usd
SIC 3826 · LABORATORY ANALYTICAL INSTRUMENTS
FIGI BBG001SF4NY1
276.67▼ 1.50 (-0.54%)
As of 2026-10-12
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
278.17
Day's Range
268.52 – 278.00
52-Week Range
88.00 – 309.35
Volume
1.6M
Avg Volume
3.3M
Share Statistics
Shares Outstanding
Employees
8,650
Exchange
XNAS
Listed
2000-07-28
Share count as of July 24, 2026

Illumina Inc (ILMN) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Illumina Inc (ILMN)
What is Illumina Inc's Market Cap?
Illumina Inc's Market Cap is $41.8B, based on as-reported figures from SEC (XBRL) filings.
What is Illumina Inc's Trailing P/E?
Illumina Inc's Trailing P/E is 50.7×, based on as-reported figures from SEC (XBRL) filings.
What is Illumina Inc's Price / Sales?
Illumina Inc's Price / Sales is 9.3×, based on as-reported figures from SEC (XBRL) filings.
What is Illumina Inc's Revenue (TTM)?
Illumina Inc's Revenue (TTM) is $4.5B, based on as-reported figures from SEC (XBRL) filings.
What is Illumina Inc's Net Income (TTM)?
Illumina Inc's Net Income (TTM) is $824.0M, based on as-reported figures from SEC (XBRL) filings.
What is Illumina Inc's EBITDA?
Illumina Inc's EBITDA is $1.2B, based on as-reported figures from SEC (XBRL) filings.
What is Illumina Inc's Diluted EPS (TTM)?
Illumina Inc's Diluted EPS (TTM) is 5.46, based on as-reported figures from SEC (XBRL) filings.
What is Illumina Inc's EBITDA Margin?
Illumina Inc's EBITDA Margin is 25.7%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ILMNAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 28, 2026Mar 29, 2026Dec 28, 2025Sep 28, 2025Jun 29, 2025Mar 30, 2025Dec 29, 2024Sep 29, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Oct 1, 2023Jul 2, 2023Apr 2, 2023Jan 1, 2023Oct 2, 2022Jul 3, 2022
Revenue:
Total revenue
YoY growth+9.4%+4.8%+5.0%+0.4%-4.8%
Cost of revenue:
Amortization of acquired intangible assets
Total cost of revenue
Gross profit
% of revenue66.4%66.1%65.5%67.6%65.6%
Operating expense:
Research and development
Selling, general and administrative
Total operating expense
% of revenue45.3%46.9%48.1%46.7%45.4%
Income from operations
% of revenue21.1%19.2%17.3%20.9%20.2%
Other income (expense):
Interest income
Interest expense
Other income (expense), net
Total other income (expense), net
Income before income taxes
Provision for income taxes
Net income
% of revenue17.9%12.3%28.8%13.8%22.2%
Basic (in dollars per share)
Diluted (in dollars per share)